Assessing the Threat: Public Health
暂无分享,去创建一个
[1] B. Biggerstaff,et al. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City , 2002, Transfusion.
[2] M. Kretzschmar,et al. Modelling the risk of transfusion transmission from travelling donors , 2016, BMC Infectious Diseases.
[3] V. Hoad,et al. Re‐evaluating the residual risk of transfusion‐transmitted Ross River virus infection , 2016, Vox sanguinis.
[4] M. Kretzschmar,et al. Estimating the transfusion transmission risk of Q fever , 2014, Transfusion.
[5] V. Sambri,et al. The Chikungunya epidemic in Italy and its repercussion on the blood system. , 2008, Blood transfusion = Trasfusione del sangue.
[6] I. Ushiro-Lumb,et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England , 2014, The Lancet.
[7] S. Ritchie,et al. Implications of Dengue Outbreaks for Blood Supply, Australia , 2013, Emerging infectious diseases.
[8] J. Desenclos,et al. Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007 , 2008, Transfusion.
[9] M. Janssen,et al. Cost‐effectiveness of the screening of blood donations for hepatitis E virus in the Netherlands , 2017, Transfusion.
[10] B. Biggerstaff,et al. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002 , 2003, Transfusion.
[11] M. Verweij,et al. Are there ethical differences between stopping and not starting blood safety measures? , 2017, Vox sanguinis.
[12] Mark Penney,et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples , 2004, The Journal of pathology.
[13] J. Linehan,et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic , 2013 .
[14] M. Koppelman,et al. Detection of parvovirus B19 DNA in blood: Viruses or DNA remnants? , 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[15] G. Bonsel,et al. The PROTON study: profiles of blood product transfusion recipients in the Netherlands , 2010, Vox sanguinis.
[16] M. Ison,et al. Current practices and evaluation of screening solid organ donors for West Nile virus , 2012, Transplant infectious disease : an official journal of the Transplantation Society.
[17] S. Görg,et al. Look‐back study on recipients of Parvovirus B19 (B19V) DNA‐positive blood components , 2015, Vox sanguinis.
[18] G. Bonsel,et al. Cost‐effectiveness of additional blood screening tests in the Netherlands , 2012, Transfusion.
[19] M. Kretzschmar,et al. Estimating the risk of dengue transmission from Dutch blood donors travelling to Suriname and the Dutch Caribbean , 2016, Vox sanguinis.
[20] E. Seifried,et al. Recipients potentially infected with parvovirus B19 by red blood cell products , 2011, Transfusion.
[21] D. Coulombier,et al. Assessing the risk of a community outbreak of hepatitis A on blood safety in Latvia, 2008. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[22] Welling Oei,et al. Modeling the transmission risk of emerging infectious diseases through blood transfusion , 2013, Transfusion.
[23] C. Promwong,et al. The risk of blood transfusion–associated Chikungunya fever during the 2009 epidemic in Songkhla Province, Thailand , 2014, Transfusion.
[24] E. Wood,et al. Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk , 2017, Transfusion Medicine Reviews.
[25] Marion C Lanteri,et al. West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety , 2014, Transfusion.
[26] F. Houston,et al. Creutzfeldt‐Jakob disease and blood transfusion safety , 2018, Vox sanguinis.